 | • レポートコード：MRC2-11QY07607 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は髄膜炎菌ワクチンのグローバル市場について調査・分析したレポートです。種類別（メナクトラ、髄膜炎菌）市場規模、用途別（肺炎、髄膜炎、細菌血症、その他（関節炎、結膜炎、尿道炎））市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別髄膜炎菌ワクチンの競争状況、市場シェア ・世界の髄膜炎菌ワクチン市場：種類別市場規模 2015年-2020年（メナクトラ、髄膜炎菌） ・世界の髄膜炎菌ワクチン市場：種類別市場規模予測 2021年-2026年（メナクトラ、髄膜炎菌） ・世界の髄膜炎菌ワクチン市場：用途別市場規模 2015年-2020年（肺炎、髄膜炎、細菌血症、その他（関節炎、結膜炎、尿道炎）） ・世界の髄膜炎菌ワクチン市場：用途別市場規模予測 2021年-2026年（肺炎、髄膜炎、細菌血症、その他（関節炎、結膜炎、尿道炎）） ・北米の髄膜炎菌ワクチン市場分析：米国、カナダ ・ヨーロッパの髄膜炎菌ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの髄膜炎菌ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の髄膜炎菌ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの髄膜炎菌ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、JN-International Medical、Novartis International、Sanofi、Pfizer、Baxter International ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Meningococcal Vaccines Market
The global Meningococcal Vaccines market size is projected to reach US$ 250.5 million by 2026, from US$ 239 million in 2020, at a CAGR of 4.4%% during 2021-2026.
Global Meningococcal Vaccines Scope and Market Size
Meningococcal Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Meningococcal Vaccines market is segmented into
Menactra
Menomune
Segment by Application, the Meningococcal Vaccines market is segmented into
Pneumonia
Meningitis
Bacteremia
Others (Arthritis, Conjunctivitis, Urethritis)
Regional and Country-level Analysis
The Meningococcal Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Meningococcal Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Meningococcal Vaccines Market Share Analysis
Meningococcal Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Meningococcal Vaccines business, the date to enter into the Meningococcal Vaccines market, Meningococcal Vaccines product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline
JN-International Medical
Novartis International
Sanofi
Pfizer
Baxter International
…
1 Study Coverage
1.1 Meningococcal Vaccines Product Introduction
1.2 Market Segments
1.3 Key Meningococcal Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Meningococcal Vaccines Market Size Growth Rate by Type
1.4.2 Menactra
1.4.3 Menomune
1.5 Market by Application
1.5.1 Global Meningococcal Vaccines Market Size Growth Rate by Application
1.5.2 Pneumonia
1.5.3 Meningitis
1.5.4 Bacteremia
1.5.5 Others (Arthritis, Conjunctivitis, Urethritis)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Meningococcal Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Meningococcal Vaccines Revenue 2015-2026
2.1.2 Global Meningococcal Vaccines Sales 2015-2026
2.2 Global Meningococcal Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Meningococcal Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Meningococcal Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Meningococcal Vaccines Competitor Landscape by Players
3.1 Meningococcal Vaccines Sales by Manufacturers
3.1.1 Meningococcal Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Meningococcal Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Meningococcal Vaccines Revenue by Manufacturers
3.2.1 Meningococcal Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Meningococcal Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Meningococcal Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Meningococcal Vaccines Revenue in 2019
3.2.5 Global Meningococcal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Meningococcal Vaccines Price by Manufacturers
3.4 Meningococcal Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Meningococcal Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Meningococcal Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Meningococcal Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Meningococcal Vaccines Market Size by Type (2015-2020)
4.1.1 Global Meningococcal Vaccines Sales by Type (2015-2020)
4.1.2 Global Meningococcal Vaccines Revenue by Type (2015-2020)
4.1.3 Meningococcal Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Meningococcal Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Meningococcal Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Meningococcal Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Meningococcal Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Meningococcal Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Meningococcal Vaccines Market Size by Application (2015-2020)
5.1.1 Global Meningococcal Vaccines Sales by Application (2015-2020)
5.1.2 Global Meningococcal Vaccines Revenue by Application (2015-2020)
5.1.3 Meningococcal Vaccines Price by Application (2015-2020)
5.2 Meningococcal Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Meningococcal Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Meningococcal Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Meningococcal Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Meningococcal Vaccines by Country
6.1.1 North America Meningococcal Vaccines Sales by Country
6.1.2 North America Meningococcal Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Meningococcal Vaccines Market Facts & Figures by Type
6.3 North America Meningococcal Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Meningococcal Vaccines by Country
7.1.1 Europe Meningococcal Vaccines Sales by Country
7.1.2 Europe Meningococcal Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Meningococcal Vaccines Market Facts & Figures by Type
7.3 Europe Meningococcal Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Meningococcal Vaccines by Region
8.1.1 Asia Pacific Meningococcal Vaccines Sales by Region
8.1.2 Asia Pacific Meningococcal Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Meningococcal Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Meningococcal Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Meningococcal Vaccines by Country
9.1.1 Latin America Meningococcal Vaccines Sales by Country
9.1.2 Latin America Meningococcal Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Meningococcal Vaccines Market Facts & Figures by Type
9.3 Central & South America Meningococcal Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Meningococcal Vaccines by Country
10.1.1 Middle East and Africa Meningococcal Vaccines Sales by Country
10.1.2 Middle East and Africa Meningococcal Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Meningococcal Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Meningococcal Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Meningococcal Vaccines Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.2 JN-International Medical
11.2.1 JN-International Medical Corporation Information
11.2.2 JN-International Medical Description and Business Overview
11.2.3 JN-International Medical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 JN-International Medical Meningococcal Vaccines Products Offered
11.2.5 JN-International Medical Related Developments
11.3 Novartis International
11.3.1 Novartis International Corporation Information
11.3.2 Novartis International Description and Business Overview
11.3.3 Novartis International Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Novartis International Meningococcal Vaccines Products Offered
11.3.5 Novartis International Related Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Description and Business Overview
11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sanofi Meningococcal Vaccines Products Offered
11.4.5 Sanofi Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Meningococcal Vaccines Products Offered
11.5.5 Pfizer Related Developments
11.6 Baxter International
11.6.1 Baxter International Corporation Information
11.6.2 Baxter International Description and Business Overview
11.6.3 Baxter International Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Baxter International Meningococcal Vaccines Products Offered
11.6.5 Baxter International Related Developments
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Meningococcal Vaccines Products Offered
11.1.5 GlaxoSmithKline Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Meningococcal Vaccines Market Estimates and Projections by Region
12.1.1 Global Meningococcal Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Meningococcal Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Meningococcal Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Meningococcal Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Meningococcal Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Meningococcal Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Meningococcal Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Meningococcal Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Meningococcal Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Meningococcal Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Meningococcal Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Meningococcal Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Meningococcal Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Meningococcal Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Meningococcal Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Meningococcal Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Meningococcal Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Meningococcal Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Meningococcal Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Meningococcal Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Meningococcal Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Meningococcal Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Meningococcal Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Meningococcal Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Meningococcal Vaccines Market Segments
Table 2. Ranking of Global Top Meningococcal Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Meningococcal Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Menactra
Table 5. Major Manufacturers of Menomune
Table 6. Global Meningococcal Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Meningococcal Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Meningococcal Vaccines Sales by Regions 2015-2020 (K Units)
Table 9. Global Meningococcal Vaccines Sales Market Share by Regions (2015-2020)
Table 10. Global Meningococcal Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Meningococcal Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Meningococcal Vaccines Sales Share by Manufacturers (2015-2020)
Table 13. Global Meningococcal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Meningococcal Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Vaccines as of 2019)
Table 15. Meningococcal Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Meningococcal Vaccines Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Meningococcal Vaccines Price (2015-2020) (USD/Unit)
Table 18. Meningococcal Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Meningococcal Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Meningococcal Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Meningococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 23. Global Meningococcal Vaccines Sales Share by Type (2015-2020)
Table 24. Global Meningococcal Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Meningococcal Vaccines Revenue Share by Type (2015-2020)
Table 26. Meningococcal Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Meningococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 28. Global Meningococcal Vaccines Sales Share by Application (2015-2020)
Table 29. North America Meningococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 30. North America Meningococcal Vaccines Sales Market Share by Country (2015-2020)
Table 31. North America Meningococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Meningococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 33. North America Meningococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 34. North America Meningococcal Vaccines Sales Market Share by Type (2015-2020)
Table 35. North America Meningococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 36. North America Meningococcal Vaccines Sales Market Share by Application (2015-2020)
Table 37. Europe Meningococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 38. Europe Meningococcal Vaccines Sales Market Share by Country (2015-2020)
Table 39. Europe Meningococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Meningococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 41. Europe Meningococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 42. Europe Meningococcal Vaccines Sales Market Share by Type (2015-2020)
Table 43. Europe Meningococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 44. Europe Meningococcal Vaccines Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Meningococcal Vaccines Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Meningococcal Vaccines Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Meningococcal Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Meningococcal Vaccines Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Meningococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Meningococcal Vaccines Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Meningococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Meningococcal Vaccines Sales Market Share by Application (2015-2020)
Table 53. Latin America Meningococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 54. Latin America Meningococcal Vaccines Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Meningococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Meningococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 57. Latin America Meningococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 58. Latin America Meningococcal Vaccines Sales Market Share by Type (2015-2020)
Table 59. Latin America Meningococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 60. Latin America Meningococcal Vaccines Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Meningococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Meningococcal Vaccines Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Meningococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Meningococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Meningococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Meningococcal Vaccines Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Meningococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Meningococcal Vaccines Sales Market Share by Application (2015-2020)
Table 69. GlaxoSmithKline Corporation Information
Table 70. GlaxoSmithKline Description and Major Businesses
Table 71. GlaxoSmithKline Meningococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. GlaxoSmithKline Product
Table 73. GlaxoSmithKline Recent Development
Table 74. JN-International Medical Corporation Information
Table 75. JN-International Medical Description and Major Businesses
Table 76. JN-International Medical Meningococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. JN-International Medical Product
Table 78. JN-International Medical Recent Development
Table 79. Novartis International Corporation Information
Table 80. Novartis International Description and Major Businesses
Table 81. Novartis International Meningococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Novartis International Product
Table 83. Novartis International Recent Development
Table 84. Sanofi Corporation Information
Table 85. Sanofi Description and Major Businesses
Table 86. Sanofi Meningococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Sanofi Product
Table 88. Sanofi Recent Development
Table 89. Pfizer Corporation Information
Table 90. Pfizer Description and Major Businesses
Table 91. Pfizer Meningococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Pfizer Product
Table 93. Pfizer Recent Development
Table 94. Baxter International Corporation Information
Table 95. Baxter International Description and Major Businesses
Table 96. Baxter International Meningococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Baxter International Product
Table 98. Baxter International Recent Development
Table 99. Global Meningococcal Vaccines Sales Forecast by Regions (2021-2026) (K Units)
Table 100. Global Meningococcal Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 101. Global Meningococcal Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 102. Global Meningococcal Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 103. North America: Meningococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 104. North America: Meningococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Europe: Meningococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 106. Europe: Meningococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Asia Pacific: Meningococcal Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 108. Asia Pacific: Meningococcal Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Latin America: Meningococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 110. Latin America: Meningococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Middle East and Africa: Meningococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 112. Middle East and Africa: Meningococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Market Risks
Table 116. Main Points Interviewed from Key Meningococcal Vaccines Players
Table 117. Meningococcal Vaccines Customers List
Table 118. Meningococcal Vaccines Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Meningococcal Vaccines Product Picture
Figure 2. Global Meningococcal Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Menactra Product Picture
Figure 4. Menomune Product Picture
Figure 5. Global Meningococcal Vaccines Sales Market Share by Application in 2020 & 2026
Figure 6. Pneumonia
Figure 7. Meningitis
Figure 8. Bacteremia
Figure 9. Others (Arthritis, Conjunctivitis, Urethritis)
Figure 10. Meningococcal Vaccines Report Years Considered
Figure 11. Global Meningococcal Vaccines Market Size 2015-2026 (US$ Million)
Figure 12. Global Meningococcal Vaccines Sales 2015-2026 (K Units)
Figure 13. Global Meningococcal Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Meningococcal Vaccines Sales Market Share by Region (2015-2020)
Figure 15. Global Meningococcal Vaccines Sales Market Share by Region in 2019
Figure 16. Global Meningococcal Vaccines Revenue Market Share by Region (2015-2020)
Figure 17. Global Meningococcal Vaccines Revenue Market Share by Region in 2019
Figure 18. Global Meningococcal Vaccines Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Meningococcal Vaccines Revenue in 2019
Figure 20. Meningococcal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Meningococcal Vaccines Sales Market Share by Type (2015-2020)
Figure 22. Global Meningococcal Vaccines Sales Market Share by Type in 2019
Figure 23. Global Meningococcal Vaccines Revenue Market Share by Type (2015-2020)
Figure 24. Global Meningococcal Vaccines Revenue Market Share by Type in 2019
Figure 25. Global Meningococcal Vaccines Market Share by Price Range (2015-2020)
Figure 26. Global Meningococcal Vaccines Sales Market Share by Application (2015-2020)
Figure 27. Global Meningococcal Vaccines Sales Market Share by Application in 2019
Figure 28. Global Meningococcal Vaccines Revenue Market Share by Application (2015-2020)
Figure 29. Global Meningococcal Vaccines Revenue Market Share by Application in 2019
Figure 30. North America Meningococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Meningococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Meningococcal Vaccines Sales Market Share by Country in 2019
Figure 33. North America Meningococcal Vaccines Revenue Market Share by Country in 2019
Figure 34. U.S. Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Meningococcal Vaccines Market Share by Type in 2019
Figure 39. North America Meningococcal Vaccines Market Share by Application in 2019
Figure 40. Europe Meningococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Meningococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Meningococcal Vaccines Sales Market Share by Country in 2019
Figure 43. Europe Meningococcal Vaccines Revenue Market Share by Country in 2019
Figure 44. Germany Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Meningococcal Vaccines Market Share by Type in 2019
Figure 55. Europe Meningococcal Vaccines Market Share by Application in 2019
Figure 56. Asia Pacific Meningococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Meningococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Meningococcal Vaccines Sales Market Share by Region in 2019
Figure 59. Asia Pacific Meningococcal Vaccines Revenue Market Share by Region in 2019
Figure 60. China Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Meningococcal Vaccines Market Share by Type in 2019
Figure 83. Asia Pacific Meningococcal Vaccines Market Share by Application in 2019
Figure 84. Latin America Meningococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Meningococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Meningococcal Vaccines Sales Market Share by Country in 2019
Figure 87. Latin America Meningococcal Vaccines Revenue Market Share by Country in 2019
Figure 88. Mexico Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Meningococcal Vaccines Market Share by Type in 2019
Figure 95. Latin America Meningococcal Vaccines Market Share by Application in 2019
Figure 96. Middle East and Africa Meningococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Meningococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Meningococcal Vaccines Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Meningococcal Vaccines Revenue Market Share by Country in 2019
Figure 100. Turkey Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Meningococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Meningococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Meningococcal Vaccines Market Share by Type in 2019
Figure 107. Middle East and Africa Meningococcal Vaccines Market Share by Application in 2019
Figure 108. North America Meningococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Meningococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Meningococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Meningococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Meningococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Meningococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Meningococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Meningococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Meningococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Meningococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
髄膜炎菌コンジュゲートの世界市場（～2026年） Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meni…- H1N1ワクチンの世界市場（～2026年） A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The global H1N1 vaccination market is anticipated to boost in the focus period due …
- ワクチンデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Vaccines Delivery Market The global Vaccines Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vaccines Delivery Scope and Market Size Vaccines Delivery market is segmented b…
- 予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…
- 細菌ワクチンの世界市場（～2026年） Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines. Rise in prevalence…